Select Medical
SEM was delisted on the 30th of June, 2026.
247 hedge funds and large institutions have $2.46B invested in Select Medical in 2023 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 72 increasing their positions, 94 reducing their positions, and 21 closing their positions.
114% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 21
70% more call options, than puts
Call options by funds: $343K | Put options by funds: $202K
10% more funds holding
Funds holding: 225 → 247 (+22)
1.42% less ownership
Funds ownership: 77.9% → 76.48% (-1.4%)
22% less capital invested
Capital invested by funds: $3.15B → $2.46B (-$697M)
23% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 94
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$9.67M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$9.29M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$7.24M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.39M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$42.8M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$39.6M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$18.6M |
| 4 |
BlackRock
New York
|
-$12.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.95M |
SEM Hedge Fund Activity: Q3 2023 in Review
247 of the 6,313 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2023, worth a combined $2.46B — down 22% from $3.15B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new SEM positions and 21 closed out — a net gain of 24 holders — while 72 added to existing stakes and 94 trimmed.
The largest buyer was Woodline Partners, adding an estimated $9.67M. The largest seller was T. Rowe Price Associates, cutting an estimated $42.8M.
- 247 institutional investors held Select Medical (SEM) as of Q3 2023, up from 225 in Q2 2023.
- Funds reported $2.46B of Select Medical stock for Q3 2023, down 22% quarter-over-quarter.
- 45 funds opened new Select Medical positions in Q3 2023 and 21 closed out, a net change of +24 holders.
- The largest Select Medical buyer in Q3 2023 was Woodline Partners, an estimated $9.67M added.
- The largest Select Medical seller in Q3 2023 was T. Rowe Price Associates, an estimated $42.8M sold.
Based on aggregated 13F filings for Q3 2023.